Clinical Trials Sponsored by Orfagen

Total 36 results

Orfagen

Completed

Evaluation of the Protection Activity of Microfine Titanium Dioxide (Ti02), Pigmentary Ti02 and Bisoctrizole and Their Combinations in Voluntary Patients With Idiopathic Solar Urticaria (SU)

Idiopathic Solar Urticaria

United States, United Kingdom
Orfagen

Completed

Efficacy, Local Tolerance and Patient Acceptability of a Moisturizing Emollient in Patients With Uremic Xerosis

Uremic Xerosis
Orfagen

Completed

Long-term Efficacy and Safety of V0034 CR 01B Cream in Patients With Moderate-to-severe Uremic Xerosis

Uremic Xerosis
ArmaGen, Inc

Completed

Safety and Dose Ranging Study of Insulin Receptor MAb-IDUA Fusion Protein in Patients With MPS I

Mucopolysaccharidosis I

United States
Kreiskrankenhaus Dormagen

Completed

Influence of Analgesia and Neuromuscular Block on Abdominal Distension and Operating Conditions Laparoscopic Operations

Neuromuscular Blockade

Germany
ArmaGen, Inc

Completed

Safety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter Syndrome

Mucopolysaccharidosis II

United States, Germany, Philippines
Kreiskrankenhaus Dormagen

Completed

Accelerometry at the Neck: Comparison With m. Adductor Pollicis Stimulation

Feasibility of Measurement of a Neuromuscular Block at the m. Trapezius

Germany
Kreiskrankenhaus Dormagen

Recruiting

Evaluation of the New Acceleromyograph TOF 3D

Neuromuscular Block | Assessment of a New Acceleromyograph

Germany
ArmaGen, Inc

Completed

Safety and Dose Ranging Study of Human Insulin Receptor MAb-IDUA Fusion Protein in Adults and Children With MPS I

Mucopolysaccharidosis I

Brazil
Kreiskrankenhaus Dormagen

Completed

Influence of Neuromuscular Block on Mask Ventilation

Effect of a Neuromuscular Block on Ventilation

Germany
ArmaGen, Inc

Completed

Extension Study of AGT-181-102 to Evaluate Long Term Safety and Activity of AGT-181

Mucopolysaccharidosis I
Kreiskrankenhaus Dormagen

Completed

Continuous Versus Intermittent Sciatic Block for Total Knee Arthroplasty

Pain | Total Knee Arthroplasty

Germany
Orfagen
FDA Office of Orphan Products Development

Completed

Systemic and Local Diffusion of Ethanol After Administration of Ethanol 96% Formulated in a Gel and Ethanol 98% Solution by the Percutaneous Route, in Patients With Congenital Venous Malformations:Pharmacokinetic, Pharmacodynamic and Clinical Study.

Congenital Venous Malformation

United States, France
Oxagen Ltd

Completed

Proof of Concept Study of OC000459 in Eosinophilic Esophagitis

Eosinophilic Esophagitis

Switzerland
Toragen, Inc.

Recruiting

Phase 1 Trial in Patients With Human Papillomavirus (HPV)-Associated Cancer

HPV Associated Cancers

United States
ArmaGen, Inc

Completed

Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Children With MPS I

Mucopolysaccharidosis I

Brazil
Kreiskrankenhaus Dormagen

Completed

Influence of a Single Dose Dexamethasone on the Time Course of Neuromuscular Blockade of Rocuronium

Neuromuscular Block, Dexamethasone | Neuromuscular Block, Recovery

Germany
Oxagen Ltd

Completed

OC000459 Dose Finding Study in Hay Fever Sufferers.

Allergic Rhinitis

Austria
Oxagen Ltd

Completed

A Study Of The Effects Of OC000459 In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis

Allergic Rhinitis

Austria
Oxagen Ltd

Completed

OC000459 Dose Finding Study in Patients With Mild to Moderate Persistent Asthma

Mild to Moderate Persistent Asthma

Bulgaria, Russian Federation, Hungary, Romania, Ukraine, Poland
Oxagen Ltd

Completed

Study to Evaluate the Potential for Interaction Between OC000459 and CYP 450 3A4

Healthy Volunteers

United Kingdom
Oxagen Ltd

Completed

Safety and Efficacy Study of OC000459 Dosed Twice Daily for 28 Days in Asthmatic Subjects

Asthma

Russian Federation
Octagen Corporation
Biomeasure Inc, Ipsen Group

Completed

Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII

Hemophilia A

United States
113 Suicide Prevention
Orygen; Mind

Not yet recruiting

#Chatsafe Netherlands: a Social Media Intervention to Improve Dutch Young People's Safe Communication About Suicide Online (CSNL)

Communication | Social Media | Suicide Prevention

Netherlands
Trevor Hansel
Oxagen Ltd

Completed

The Effects of OC000459 on Nasal Mediators

Allergic Rhinitis

United Kingdom
Orygen
University of Melbourne; Youth Support and Advocacy Service

Recruiting

Guanfacine Extended-release for Adolescents With Cannabis Use (GRACE)

Cannabis Use Disorder

Australia
Chengdu Origen Biotechnology Co., Ltd.

Recruiting

Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Age-Related Macular Degeneration

China
Oxagen Ltd
King's College Hospital NHS Trust; Medicines Evaluation Unit, Manchester, UK

Completed

OC000459 Bronchial Allergen Challenge

Bronchial Asthma

United Kingdom
Chengdu Origen Biotechnology Co., Ltd.

Recruiting

Safety and Tolerability of KH631 Gene Therapy in Participants With Neovascular Age-related Macular Degeneration

Age-Related Macular Degeneration

United States
Oswaldo Cruz Foundation
IDRI; Biomedical Research Center EPLS; Orygen Biotecnologia SA

Completed

Anti-Schistosomiasis Vaccine: Sm14 Phase 2b-Sn in School Children

Schistosomiasis

Senegal
Oswaldo Cruz Foundation
IDRI; Biomedical Research Center EPLS; Orygen Biotecnologia SA

Completed

Study of Safety and Immune Response of the Sm14 Vaccine in Adults of Endemic Regions

Schistosomiasis

Senegal
Brigham and Women's Hospital
National Institute of Mental Health (NIMH); Yale University; Orygen

Recruiting

AMP SCZ® Observational Study: PREDICT-DPACC (AMP SCZ)

Psychosis | Remission | Conversion | Clinical High Risk

United States, United Kingdom, Canada, Italy, Australia, Chile, China, Denmark, Germany, Hong Kong, Korea, Republic of, Singapore, Spain, Switzerland
Clínica Origen
ANDROFERT - Clinica de Andrologia e Reproducao Humana; Faculdade de Medicina...

Unknown

Pharmacogenetic Algorithm for Individualized Controlled Ovarian Stimulation

Infertility
Orygen
National Health and Medical Research Council, Australia; University of Melbourne and other collaborators

Completed

Promotion of Self-help Strategies for Depression

Depressive Disorder | Depression

Australia
Bambino Gesù Hospital and Research Institute
National Alliance for Research on Schizophrenia and Depression; Orygen

Unknown

Indicated Prevention With Long-chain Polyunsaturated Omega-3 Fatty Acids in Patients With 22q11 Microdeletion Syndrome.

22q11 Deletion Syndrome

Holy See (Vatican City State)
Orygen
National Institute of Mental Health (NIMH); University of California, Davis; University...

Unknown

The Staged Treatment in Early Psychosis Study (STEP)

Personality Disorders | Psychotic Disorders | Clinical High Risk

Australia

Clinical Trials Sponsored by Orfagen

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations